New Global Consortium Forms To Aid Ebola Response In DRC, Launch 2nd Experimental Vaccine; J&J Donating 500K Doses

Bloomberg: Johnson & Johnson Giving 500,000 Ebola Shots in Congo Test
“Johnson & Johnson will donate as many as half a million doses of its experimental Ebola vaccine for a trial in the Democratic Republic of the Congo, where more than 2,000 people have died in the latest outbreak. The vaccine will be studied in areas outside the ‘hot zone’ where cases are spreading most quickly, J&J research chief Paul Stoffels said…” (Lauerman, 10/31).

CIDRAP News: Consortium readies for launch of 2nd Ebola vaccine in DRC
“A global consortium that includes the Democratic Republic of the Congo (DRC) ministry of health, Doctors without Borders, the Wellcome Trust, and CEPI (the Coalition for Epidemic Preparedness Innovations), among other groups, is preparing for the introduction of a second Ebola vaccine to be used in the DRC in the coming days…” (Soucheray, 10/31).

Devex: Ebola in DRC: NGOs organize to coordinate community engagement work
“NGOs responding to the Ebola emergency in the Democratic Republic of the Congo have formed a consortium to help better involve communities…” (Jerving, 11/1).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.